Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Diagnostics and Medical Technology›Radionuclide Angiography

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Radionuclide Angiography

Diagnostics and Medical Technology · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (753 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply. It is used to diagnose heart, liver, lung, and other diseases and to measure the function of those organs, except renography, for which radioisotope renography is available.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Angiography, Radioisotope; Angiographies, Radioisotope; Radioisotope Angiographies; Radioisotope Angiography; Angiography, Radionuclide; Angiographies, Radionuclide; Radionuclide Angiographies.

Where it fits in the MeSH classification

Broader topics
Radionuclide Imaging; Angiography
Narrower topics
Radioisotope Renography; Radionuclide Ventriculography

Related concepts

  • Radioisotope Renography

Research landscape

PubMed indexes 9,350 records tagged with the MeSH heading “Radionuclide Angiography” (counts retrieved 2026-11-04). 130 of them (1.4%) were published from 2020 onward, and the busiest period so far is through 1999 with 6,598 records.

Reviews account for 691 records (7.4%) and meta-analyses for 12. Randomized controlled trials number 233 (2.5%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 6,598 records; 2000-2009: 1,902 records; 2010-2019: 720 records; 2020 onward: 130 records6,598through 19991,9022000-20097202010-20191302020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19996,598
2000-20091,902
2010-2019720
2020 onward130
Share of records by publication typeReviews: 7.4 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 2.5 percentReviews7.4% (691)Meta-analyses0.1% (12)Randomized controlled trials2.5% (233)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 9,350 PubMed records
TypeRecordsShare
Reviews6917.4%
Meta-analyses120.1%
Randomized controlled trials2332.5%

Method: PubMed query "Radionuclide Angiography"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.

Reading the evidence in diagnostics and medical technology

A test or device is judged by how well it detects a condition, how often it gives false alarms or misses cases, and whether using it improves outcomes for people. Accuracy depends on who is tested and how common the condition is, so a test that performs well in a specialist hospital can perform differently in the community. Check the reference standard, the population studied, the sensitivity and specificity and whether results were confirmed in a separate group.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography
Skovgaard D, Hasbak P, Kjaer A
2014Research article
Design not recorded in structured metadata
78cc by
PMID 24800827 · DOI · PMC4011788
Comparison of phase dyssynchrony analysis using gated myocardial perfusion imaging with four software programs: Based on the Japanese Society of Nuclear Medicine working group normal database
Nakajima K, Okuda K, Matsuo S, Kiso K, Kinuya S, Garcia EV
2017Research article
Design not recorded in structured metadata
59cc by
PMID 26860109 · DOI · PMC5413527
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, et al.
2016Research article
Design not recorded in structured metadata
21cc by
PMID 26048264 · DOI · PMC4956716
Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors
Eum SH, Lee H, Ko EJ, Cho HJ, Yang CW, Chung BH
2022Research article
Design not recorded in structured metadata
8cc by
PMID 35332250 · DOI · PMC8948196

BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography [1]

Research article Skovgaard D, Hasbak P, Kjaer A · · 2014 · cited 78 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
UnlabelledCardiotoxicity is a dose-limiting side-effect of cancer chemotherapeutics such as anthracyclines.
Closing excerpt
This prospective study based on the hitherto largest study population supports BNP as a clinical relevant method for monitoring chemotherapy-related cardiac failure and death.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (239 words)

UnlabelledCardiotoxicity is a dose-limiting side-effect of cancer chemotherapeutics such as anthracyclines. The drug-induced cardiac toxicity is currently monitored with repeated assessments of the left ventricular ejection fraction (LVEF) using multigated equilibrium radionuclide ventriculography (MUGA) or echocardiography. However, the plasma cardiac biomarker B-type natriuretic peptide (BNP) has been suggested for early identification of cardiac dysfunction. The aim of the study was to compare LVEF obtained by MUGA and plasma BNP as predictors of developing congestive heart failure (CHF) or death in a population of anthracycline-treated cancer patients.MethodsWe prospectively followed 333 cancer patients referred to our department for routine monitoring of LVEF with MUGA and measurement of BNP, January-December 2004. Study end points were hospitalization for CHF and death during follow-up 2004-2010. Data were obtained from the Danish National Patient Registry.ResultsDuring follow-up (mean 1,360 days), 21 of the patients were admitted to hospital with a diagnosis of CHF and 194 of the patients died. BNP levels were significantly higher and LVEF lower in the group of patients that developed CHF. Using cut-off points of BNP>100 pg/ml (HR 5.5; CI 1.8-17.2; p = 0.003) and LVEF ConclusionIn cancer patients treated with cardiotoxic chemotherapy both BNP and LVEF can significantly predict subsequent hospitalization with CHF. In addition, BNP and not LVEF has a prognostic value in detecting overall death. This prospective study based on the hitherto largest study population supports BNP as a clinical relevant method for monitoring chemotherapy-related cardiac failure and death.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 24800827 · DOI · PMC4011788

Comparison of phase dyssynchrony analysis using gated myocardial perfusion imaging with four software programs: Based on the Japanese Society of Nuclear Medicine working group normal database [2]

Research article Nakajima K, Okuda K, Matsuo S, Kiso K, Kinuya S, Garcia EV · · 2017 · cited 59 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
PurposeLeft ventricular (LV) phase dyssynchrony parameters based on gated myocardial perfusion imaging varied among software programs.
Closing excerpt
3 for QGS (P ConclusionBased on normal ranges of phase dyssynchrony parameters in four software programs, dependency on genders, LV volume, and EF should be considered, indicating the need for careful comparison among different software programs.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (125 words)

PurposeLeft ventricular (LV) phase dyssynchrony parameters based on gated myocardial perfusion imaging varied among software programs. The aim of this study was to determine normal ranges and factors affecting phase parameters.MethodsNormal databases were derived from the Japanese Society of Nuclear Medicine working group (n = 69). The programs were Emory Cardiac Toolbox with SyncTool (ECTb), Quantitative Gated SPECT (QGS), Heart Function View (HFV), and cardioREPO (cREPO); parameters of phase standard deviation (PSD), 95% bandwidth, and entropy were compared with parameters with ECTb as a reference.ResultsPSD (degree) was 5.3 ± 3.3 for QGS (P ConclusionBased on normal ranges of phase dyssynchrony parameters in four software programs, dependency on genders, LV volume, and EF should be considered, indicating the need for careful comparison among different software programs.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26860109 · DOI · PMC5413527

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA) [3]

Research article Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, et al. · · 2016 · cited 21 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundTrastuzumab is successfully used for the treatment of HER2-positive breast cancer.
Closing excerpt
An impairment of MUGA-derived diastolic parameters does not occur prior to SD and therefore cannot be used as earlier predictors of TIC.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (190 words)

BackgroundTrastuzumab is successfully used for the treatment of HER2-positive breast cancer. Because of its association with cardiotoxicity, LVEF is monitored by MUGA, though this is a relatively late measure of cardiac function. Diastolic dysfunction (DD) is believed to be an early predictor of cardiac impairment. We evaluate the merit of MUGA-derived diastolic function parameters in the early detection of trastuzumab-induced cardiotoxicity (TIC).Methods and results77 trastuzumab-treated patients with normal baseline systolic and diastolic function were retrospectively selected (n = 77). All serial MUGA examinations were re-analyzed for systolic and diastolic function parameters. 36 patients (47%) developed SD and 45 patients (58%) DD during treatment. Both systolic and diastolic parameters significantly decreased. Of the patients with SD, 24 (67%) also developed DD. DD developed prior to systolic impairment in 54% of cases, in 42% vice versa, while time to occurrence did not differ significantly (P = .52). This also applied to the subgroup of advanced stage breast cancer patients (P = .1).ConclusionsTrastzumab-induced SD and DD can be detected by MUGA. An impairment of MUGA-derived diastolic parameters does not occur prior to SD and therefore cannot be used as earlier predictors of TIC.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26048264 · DOI · PMC4956716

Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors [4]

Research article Eum SH, Lee H, Ko EJ, Cho HJ, Yang CW, Chung BH · · 2022 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Computed tomography (CT) and nuclear renography are used to determine kidney procurement in living kidney donors (LKDs).
Closing excerpt
In conclusion, CT volumetry is preferred when determining procurement strategy especially when discordance is found between the two imaging modalities.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (199 words)

Computed tomography (CT) and nuclear renography are used to determine kidney procurement in living kidney donors (LKDs). The present study investigated which modality better predicts kidney function after donation. This study included 835 LKDs and they were divided into two subgroups based on whether the left-right dominance of kidney volume was concordant with kidney function (concordant group) or not (discordant group). The predictive value for post-donation kidney function between the two imaging modalities was compared at 1 month, 6 months, and > 1 year in total cohort, concordant, and discordant groups. Split kidney function (SKF) measured by both modalities showed significant correlation with each other at baseline. SKFs of remaining kidney measured using both modalities before donation showed significant correlation with eGFR (estimated glomerular filtration rate) after donation in the total cohort group and two subgroups, respectively. CT volumetry was superior to nuclear renography for predicting post-donation kidney function in the total cohort group and both subgroups. In the discordant subgroup, a higher tendency of kidney function recovery was observed when kidney procurement was determined based on CT volumetry. In conclusion, CT volumetry is preferred when determining procurement strategy especially when discordance is found between the two imaging modalities.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35332250 · DOI · PMC8948196

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction [5]
    Prasad A, Lerman A, Rihal CS · Am Heart J · 2008 · cited 1,256 times (Europe PMC)
  • Research article Prognostic value of gated myocardial perfusion SPECT [6]
    Shaw LJ, Iskandrian AE · J Nucl Cardiol · 2004 · cited 423 times (Europe PMC)
  • Research article Guidelines for the measurement of glomerular filtration rate using plasma sampling [7]
    Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS, British Nuclear Medicine Society · Nucl Med Commun · 2004 · cited 224 times (Europe PMC)
  • Research article Report of the Radionuclides in Nephrourology Committee on renal clearance [8]
    Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, et al. · J Nucl Med · 1996 · cited 203 times (Europe PMC)
  • Research article Iodinated blood pool contrast media for preclinical X-ray imaging applications--a review [9]
    Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T · Biomaterials · 2010 · cited 157 times (Europe PMC)
  • Research article The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council--The Society of Nuclear Medicine [10]
    Conway JJ, Maizels M · J Nucl Med · 1992 · cited 154 times (Europe PMC)

References

  1. Skovgaard D, Hasbak P, Kjaer A. BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography. . 2014. PMID 24800827 · DOI · PMC4011788
  2. Nakajima K, Okuda K, Matsuo S, Kiso K, Kinuya S, Garcia EV. Comparison of phase dyssynchrony analysis using gated myocardial perfusion imaging with four software programs: Based on the Japanese Society of Nuclear Medicine working group normal database. . 2017. PMID 26860109 · DOI · PMC5413527
  3. Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, et al.. Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA). . 2016. PMID 26048264 · DOI · PMC4956716
  4. Eum SH, Lee H, Ko EJ, Cho HJ, Yang CW, Chung BH. Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors. . 2022. PMID 35332250 · DOI · PMC8948196
  5. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008. PMID 18294473 · DOI
  6. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004. PMID 15052249 · DOI
  7. Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS, British Nuclear Medicine Society. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun. 2004. PMID 15266169 · DOI
  8. Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, et al.. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med. 1996. PMID 8917197 · DOI
  9. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical X-ray imaging applications--a review. Biomaterials. 2010. PMID 20510444 · DOI
  10. Conway JJ, Maizels M. The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council--The Society of Nuclear Medicine. J Nucl Med. 1992. PMID 1432172

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Radionuclide VentriculographyDiagnostics and Medical Technology
  • Coronary AngiographyDiagnostics and Medical Technology
  • Myocardial Perfusion ImagingDiagnostics and Medical Technology
  • Radionuclide ImagingDiagnostics and Medical Technology
  • AortographyDiagnostics and Medical Technology
  • EchocardiographyDiagnostics and Medical Technology

All 110 articles in Diagnostics and Medical Technology →

At a glance

9,350
PubMed records on this heading
1%
published since 2020
691
review articles
233
randomized trials
10
verified references below

Counts come from PubMed on 2026-11-04; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Radionuclide VentriculographyDiagnostics and Medical Technology
  • Coronary AngiographyDiagnostics and Medical Technology
  • Myocardial Perfusion ImagingDiagnostics and Medical Technology
  • Radionuclide ImagingDiagnostics and Medical Technology
  • AortographyDiagnostics and Medical Technology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support